[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key […]
Continue readingTag: Markets
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
[ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little […]
Continue reading
Jim Cramer says GE Healthcare's unwarranted post-earnings plunge is a buying opportunity
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Wells Fargo becomes bullish on this biotech company
[ad_1] Neurocrine Biosciences ‘ drug pipeline is turning a corner and the company will be “knocking on the doors of the large-cap club” soon, according […]
Continue reading
Promise of Eli Lilly's weight-loss drug for sleep apnea adds another reason to own the stock
[ad_1] Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s […]
Continue reading
Abbott Labs' surprise guidance bump is a major positive for its shareholders
[ad_1] Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by […]
Continue reading
We're buying more of this health-care company amid an overdone sell-off
[ad_1] Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust […]
Continue reading
Nvidia stomps the bears. Plus, Cramer's thoughts on 2 struggling portfolio names
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Jim Cramer defends Elon Musk's use of ketamine for depression: The CEO 'saved a lot of lives'
[ad_1] CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and “saved a lot of people […]
Continue reading
Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading